Skip to main content

Advertisement

Log in

Radical Redo Surgery for Local Rectal Cancer Recurrence Improves Overall Survival: A Single Center Experience

  • original article
  • Published:
Journal of Gastrointestinal Surgery

Abstract

Background

To date, the survival benefit of redo surgery in locally recurrent rectal adenocarcinoma remains unclear.

Study Design

In an institutional study, operations for recurrence were retrospectively analyzed. Survival was calculated using the Kaplan–Meier plot and Cox regression analysis.

Results

A total of 72 patients with local recurrence were explored or resected. In 38 patients, there was synchronous distant organ recurrence. Forty-five of 72 were re-resected and in 37 of 45 cases, R0 situations were achieved. In 11 of 38 metastasized patients, both local and distant organ recurrence were successfully removed. For obtaining tumor control, resections of inner genitals, bladder, and sacral bone were necessary in 10, 4, and 11 patients, respectively. Survival was better for patients re-resected with a median overall survival of 54.9 months, as compared with 31.1 months among non-resected patients (p = 0.0047, log-rank test). Subgroup analysis revealed that a benefit of re-resection was observed to a lesser extent in synchronous local and in distant disease. Cox analysis showed that initial Dukes stage and complete resections of local recurrences were independently determining prognosis (relative risk 1.762 and 0.689, p = 0.008 and p = 0.002, respectively).

Conclusions

Radical surgery for local recurrence can improve survival if complete tumor clearance is achieved, and concomitant distant tumor load should not principally preclude re-resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

Reference

  1. Tschmelitsch J, Kronberger P, Prommegger R, Reibenegger G, Glaser K, Bodner E. Survival and local recurrence after anterior resection and abdominoperineal excision for rectal cancer. Eur J Surg Oncol 1995;21(6):640–643 (December).

    Article  PubMed  CAS  Google Scholar 

  2. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–1740 (October 21).

    Article  PubMed  CAS  Google Scholar 

  3. Visser O, Bakx R, Zoetmulder FA, Levering CC, Meijer S, Slors JF et al. The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: a population-based study in greater Amsterdam. J Surg Oncol 2007;95:447–454 (October 17).

    Article  PubMed  CAS  Google Scholar 

  4. Heald RJ. Local recurrence of rectal cancer. Dis Colon Rectum 1987;30(7):572 (July).

    Article  PubMed  CAS  Google Scholar 

  5. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638–646 (August 30).

    Article  PubMed  CAS  Google Scholar 

  6. Compton CC, Henson DE, Hutter RV, Sobin LH, Bowman HE. Updated protocol for the examination of specimens removed from patients with colorectal carcinoma. A basis for checklists. Arch Pathol Lab Med 1997;121(12):1247–1254 (December).

    PubMed  CAS  Google Scholar 

  7. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med 2000;124(7):1016–1025 (July).

    PubMed  CAS  Google Scholar 

  8. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 2006;130(3):318–324 (March).

    PubMed  Google Scholar 

  9. Dent OF, Haboubi N, Chapuis PH, Chan C, Lin BP, Wong SK et al. Assessing the evidence for an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Colorectal Dis 2007;9(2):112–121 (February).

    Article  PubMed  CAS  Google Scholar 

  10. Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351(4):337–345 (July 22).

    Article  PubMed  CAS  Google Scholar 

  11. Read TE, Mutch MG, Chang BW, McNevin MS, Fleshman JW, Birnbaum EH et al. Locoregional recurrence and survival after curative resection of adenocarcinoma of the colon. J Am Coll Surg 2002;195(1):33–40 (July).

    Article  PubMed  Google Scholar 

  12. Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996;39(3):323–328 (March).

    Article  PubMed  CAS  Google Scholar 

  13. Khera G, Walsh CJ, Anderson JA, El-Sayed TY, Haylock BJ, Myint AS et al. Local recurrence after curative resection for rectal cancer—role of the multi-disciplinary team. Colorectal Dis 2007;9(2):187 (February).

    Article  Google Scholar 

  14. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099–1107 (August).

    Article  PubMed  Google Scholar 

  15. Swedish Rectal Cancer Trial. Local recurrence rate in a randomised multicentre trial of preoperative radiotherapy compared with operation alone in resectable rectal carcinoma. Eur J Surg 1996;162(5):397–402 (May).

    Google Scholar 

  16. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336(14):980–987 (April 3).

    Article  Google Scholar 

  17. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345(9):638–646 (August 30).

    Article  PubMed  CAS  Google Scholar 

  18. Rodel C, Sauer R. Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer. Recent Results Cancer Res 2005;165:221–230.

    Article  PubMed  Google Scholar 

  19. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B. Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 2007;94(1):113–118 (January).

    Article  PubMed  CAS  Google Scholar 

  20. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351(17):1731–1740 (October 21).

    Article  PubMed  CAS  Google Scholar 

  21. Nagtegaal ID, van de Velde CJH, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005;23(36):9257–9264 (December 20).

    Article  PubMed  Google Scholar 

  22. Kapiteijn E, van de Velde CJH. Developments and quality assurance in rectal cancer surgery. Eur J Cancer 2002;38(7):919–936 (May).

    Article  PubMed  CAS  Google Scholar 

  23. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol 1999;25(4):368–374 (August).

    Article  PubMed  CAS  Google Scholar 

  24. Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, Dutch ColoRectal Cancer Group et al. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Eur J Surg 1999;165(5):410–420 (May).

    Article  PubMed  CAS  Google Scholar 

  25. Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJH. Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome. Br J Surg 1998;85(1):92–97 (January).

    Article  PubMed  CAS  Google Scholar 

  26. Hahnloser D, Nelson H, Gunderson LL, Hassan I, Haddock MG, O’Connell MJ et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003;237(4):502–508 (April).

    Article  PubMed  Google Scholar 

  27. Melton GB, Paty PB, Boland PJ, Healey JH, Savatta SG, Casas-Ganem JE et al. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 2006;49(8):1099–1107 (August).

    Article  PubMed  Google Scholar 

  28. Griffin MR, Bergstralh EJ, Coffey RJ, Beart RW Jr., Melton LJ III. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer 1987;60(9):2318–2324 (November 1).

    Article  PubMed  CAS  Google Scholar 

  29. Sigurdsson HK, Korner H, Dahl O, Skarstein A, Soreide JA. Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study. Dis Colon Rectum 2007;50:285–288 (January 22).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paulus Schurr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schurr, P., Lentz, E., Block, S. et al. Radical Redo Surgery for Local Rectal Cancer Recurrence Improves Overall Survival: A Single Center Experience. J Gastrointest Surg 12, 1232–1238 (2008). https://doi.org/10.1007/s11605-008-0517-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-008-0517-8

Keywords

Navigation